Page 20 - Morphosys All The Shares News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys all the shares. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys All The Shares Today - Breaking & Trending Today

EQS-News: Chief Financial Officer Sung Lee to Leave MorphoSys in March 2023 Seite 1

20.12.2022 - EQS-News: MorphoSys AG / Key word(s): Miscellaneous Chief Financial Officer Sung Lee to Leave MorphoSys in March 2023 20.12.2022 / 22:01 CET/CEST The issuer is solely responsible for the content of this announcement. Media Release Planegg/Munich, . Seite 1 ....

United States , Jean Paul Kress , Marc Cluzel , Constellation Pharmaceuticals , Financial Officer Sung Lee , Leave Morphosys , Sung Lee , Chief Financial Officer , Management Board , Supervisory Board , Executive Committee , Chief Executive Officer , Qs News ,

MorphoSys, Novartis To Research & Commercialize Pre-clinical Inhibitors Of Novel Cancer Target

BASEL (dpa-AFX) - MorphoSys AG (MOR) said that its subsidiary Constellation Pharmaceuticals has reached a global licensing agreement with Novartis to research, develop and commercialize its pre-clinical ....

Constellation Pharmaceuticals ,

MorphoSys AG: Financial Calendar 2023

PLANEGG / MUNICH, GERMANY / ACCESSWIRE / November 28, 2022 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) publishes its financial calendar dates for the year 2023:Publication of Interim Statement / ReportConference ....

United States , Kaitlyn Nealy , Thomas Biegi , Julia Neugebauer , Morphosys Agview , Exchange Commission , Interim Statement , End Results , Quarter Interim Statement , Year Report , Morphosy Annual Report ,

MorphoSys AG Q3 Loss Climbs

MARTINSRIED (dpa-AFX) - MorphoSys AG (MOR) revealed Loss for its third quarter that increased from last yearThe company's bottom line came in at -Euro122.9 million, or -Euro3.60 per share. This ....